Price elasticity of demand for cannabis: post-legalization estimates of the regulated cannabis market in British Columbia, Canada

  • 0BC Ministry of Public Safety and Solicitor General. Electronic address: taylor.dodd@gov.bc.ca.
The International journal on drug policy +

|

Abstract

BACKGROUND

Cannabis was legalized in Canada for adult non-medical use in 2018, thereby changing how and where consumers buy cannabis. Prices have continued to decrease since legalization, and there is ongoing competition between regulated and illicit operators. Given these conditions, the aim of this study was to estimate the price elasticity of demand for regulated cannabis.

METHODS

Data were monthly product-level wholesale sales from June 2022 to May 2024 from B.C.'s provincial cannabis wholesaler. We estimated price elasticity of demand for regulated cannabis in B.C. using ordinary least squares regression with fixed effects and controls for supply-side and demand-side factors, including brand, time, number of retailers a product was sold to, and THC and CBD content.

RESULTS

Demand for regulated cannabis was found to be price elastic. Specifically, a 10 percent decrease in regulated cannabis price was associated with a 14 percent increase in the quantity of cannabis purchased in B.C. during the study period.

CONCLUSION

Although pre-legalization studies have observed price inelastic demand for cannabis, this study provides the first post-legalization estimate for regulated cannabis in Canada. Price elastic demand for regulated cannabis in B.C. may result from competition between regulated and illicit cannabis producers and retailers, and the willingness of some consumers to substitute between these sources based on price. These findings provide further insight into the continued displacement of the illicit cannabis market and challenges associated with pricing and taxation for regulated cannabis businesses.

Related Concept Videos

Drug Control Governance: Regulatory Bodies and Their Impact 01:03

132

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids 01:21

198

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...

Drug Regulation 01:25

1.3K

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...

Analysis of Population Pharmacokinetic Data 01:12

205

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

Elasticity 01:12

3.4K

Elasticity is the ability of an object to withstand the effects of distortion and to return to its original size and shape once the forces causing deformation are removed. When an elastic material deforms under the action of an external force, it experiences internal resistance to the deformation. However, if no external force is applied, it returns to its original state.
The elasticity of an object can be described by a stress-strain curve, which represents the relationship between stress...